Tag: Competition

Displaying 1441 - 1460 of 2499 results.

Pages

Federal Trade Commission Chairman Jon Leibowitz and Justice Department Acting Assistant Attorney General Joseph Wayland participated in high-level meetings with officials from China’s three antitrust agencies – Ministry of Commerce (MOFCOM) Vice Minister Gao Hucheng, National Development and...
On 9/25/2012, Biglari Holdings, Inc., a publicly traded holding company, agreed to pay $850,000 to resolve Federal Trade Commission allegations that it violated premerger reporting laws in connection with its 2011 acquisition of a stake in the restaurant operator Cracker Barrel Old...
The Federal Trade Commission has closed its nonpublic investigation of the proposed acquisition by Vivendi, S.A., parent company of Universal Music Group, of EMI Recorded Music without taking any action, and Bureau of Competition Director Richard Feinstein has issued a related statement.
The Federal Trade Commission has reopened the public comment period for next month's workshop focusing on competition and consumer protection issues in the pet medications industry, and will now accept comments through November 1, 2012. The Commission is seeking the views of consumers,...
The Federal Trade Commission has posted an agenda for next month’s workshop focusing on the pet medications industry in the United States.  FTC Chairman Jon Leibowitz is scheduled to provide opening remarks, and will be joined at the event by industry members, veterinarians, and other...
Federal Trade Commission staff, in response to a request from West Virginia State Senator Daniel Foster, provided testimony to a state legislative panel stating that making it simpler for Advanced Practice Registered Nurses (APRNs) to prescribe medications could benefit West Virginia health care...
Following a public comment period, the Federal Trade Commission has approved a final order settling charges that Novartis AG's proposed acquisition of Fougera Holdings, Inc. was anticompetitive in the markets for the marketing rights to four topical skin care medications.
Following a public comment period, the Federal Trade Commission has approved a modified final order settling charges that CoStar Group, Inc.'s $860 million acquisition of Loopnet would have been anticompetitive in the market for commercial real estate information services in the United States.
The Federal Trade Commission has closed its nonpublic investigation of Facebook's proposed acquisition of Instagram, Inc., without taking any action. Accordingly, the deal may now proceed as proposed. The Commission vote to close the investigation was 5-0. The closing letters to the companies can...
A Puerto Rican cooperative of pharmacy owners, Cooperativa de Farmacias Puertorriqueñas, known as "Coopharma," agreed to settle Federal Trade Commission charges that it harmed competition by negotiating, entering into, and implementing agreements among its member pharmacies to fix...
A Puerto Rican cooperative of pharmacy owners, Cooperativa de Farmacias Puertorriquenas, known as "Coopharma," has agreed to settle Federal Trade Commission charges that it harmed competition by negotiating, entering into, and implementing agreements among its member pharmacies to fix prices on...
The Federal Trade Commission has submitted its Brief for the Petitioner with the U.S. Supreme Court in Phoebe Putney Health System, Inc., a case in which the FTC challenged the proposed merger of Phoebe Putney Health System and Palmyra Park Hospital in Albany, Georgia.
The Federal Trade Commission and the Department of Justice announced today that they will hold a joint public workshop on most-favored-nation clauses (MFNs) on Sept.10, 2012, to explore the use of MFN clauses and the implications for antitrust enforcement and policy. 
Following a public comment period, the Federal Trade Commission has approved a final order settling charges that Koninklijke Ahold N.V.'s proposed acquisition of Genuardi's supermarkets would have been anticompetitive in the local grocery market in Newtown, Pennsylvania. The final order resolving...
The Federal Trade Commission is seeking public comments on proposed changes to the premerger notification rules that could require companies in the pharmaceutical industry to report proposed acquisitions of exclusive patent rights to the FTC and the Department of Justice for antitrust review. The...
The Federal Trade Commission's Bureau of Competition staff has issued an advisory opinion letter, in response to a request from the Generic Pharmaceutical Association (GPhA), stating that the staff will not recommend a challenge to an initiative intended to help the U.S. Food and Drug...
Following a public comment period, the Federal Trade Commission has approved a final order settling charges that Johnson & Johnson's proposed acquisition of Synthes, Inc. would have been anticompetitive in the market for surgical systems used to treat traumatic distal radius wrist fractures....
Renown Health agreed to settle charges that its acquisitions of two local cardiology groups reduced competition for the provision of adult cardiology services in the Reno area. Renown Health, based in Reno, Nevada, operates general acute care hospitals and commercial health plans...

Pages